XLEI ranks 3rd and BIOY 21st of 22 funds in the Sector Option Income Category.
BIOY vs XLEI
XLEI −14.63pt a year
14.98%0.35%
XLEI 82.7×the volume
2.54K210K
BIOY vs XLEI Performance
+5.9%+6.6%
- BIOY 14.98%
- XLEI 0.35%, better
- BIOY $2M
- XLEI $196M
- BIOY
- XLEI +33.3%
- BIOY
- XLEI 20.10%
- BIOY 7
- XLEI 2
- BIOY 2.54K sh
- XLEI 210K sh, better
- BIOY $18.92
- XLEI $26.47
ETF.net Grade
| Pillar | BIOY | XLEI |
|---|---|---|
| Cost | F0 | A76Higher |
| Mission | A80 | |
| Risk | B60 | B62Higher |
| Tradability | F24 | A70Higher |
| Holdings | C53 | |
| Durability | D27 | A81Higher |
Rank among Sector Option Income funds
Same Category. BIOY and XLEI are both graded against the same 22 Sector Option Income funds, so their Grades compare head to head.
Our read on each fund
BIOYF
XLEIA
In short
BIOY Most sector income funds sell calls on the sector itself. BIOY goes one level up: it sells puts on a 3x leveraged biotech ETF, mining the fat premiums that come with one of the market's twitchiest wrappers, and pays cash out weekly.
XLEI State Street's 1998-vintage energy sector fund, wrapped in a call-writing overlay. Same oil and gas majors, monthly income from selling options against them, minus some of the upside when crude runs.
Stated mandate
BIOY The Fund seeks to generate three times the income from selling options on the S&P Biotechnology Select Industry Index through options on leveraged ETFs, while also seeking exposure to the leveraged ETF’s performance subject to a cap.
XLEI The fund seeks current income while preserving prospects for long-term capital growth by investing in an energy-sector ETF and selling call options on it to generate additional premium income.
Why people hold it
Worth knowing
BIOY vs XLEI Holdings
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
BIOY vs XLEI Cost
Overpaying BIOY vs XLEI
$68,172
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
BIOY 14.98%
$75,298
XLEI 0.35%
$7,126
Cost over time
Year by year
| Year | BIOY | XLEI | Overpaying |
|---|---|---|---|
| 10 | $15,318 | $634 | $14,684 |
| 20 | $36,802 | $2,454 | $34,348 |
| 30 | $75,298 | $7,126 | $68,172 |
- 14.98%BIOY
- 0.35%XLEI, cheaper
- Middle half of Sector Option Income funds
- Median 0.47%
XLEI cheapest of 22 funds
BIOY 22nd cheapest of 22 funds
BIOY vs XLEI Dividends
- BIOY
- XLEI 20.10%
- BIOY
- XLEI $5.35
- BIOY $0.22
- XLEI $0.50
- BIOY Nov 6, 2026
- XLEI Nov 2, 2026
- BIOY Pays Nov 10, 2026
- XLEI Nov 4, 2026
- BIOY Weekly
- XLEI Monthly
Distribution history
BIOY vs XLEI Risk
Fall from peak · 5 years
Risk facts
- Volatility
- BIOY XLEI 15.6%
- Return per unit of risk
- BIOY XLEI 2.03
- Worst fall
- BIOY XLEI −9.5%
- Market sensitivity
- BIOY 0.56XLEI −0.55
BIOY and XLEI in the news
Popular comparisons
- 14.98% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.35% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 14.98% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.35% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 14.98% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.35% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
